DOCSLIB.ORG

Synthetic Cannabinoid Fact Sheet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synthetic Cannabinoid Fact Sheet Synthetic Cannabinoid Fact Sheet 09 June 2016 What is synthetic marijuana? Why do people use synthetic cannabinoid “Synthetic marijuana” is a common, but misleading, products like “Spice” and “K2?” term that refers to a class of substances more The emergence of synthetic cannabinoids has accurately called cannabinoid receptor agonists or mirrored the same trends seen with other novel synthetic cannabinoids.i Whereas marijuana usually psychoactive substances. People may use synthetic refers to the dried flowered buds of the actual plant, cannabinoids when experimenting with other which derives its main psychoactive effect through substances, and in some cases use may be THCii, synthetic cannabinoids get their name from their accidental. action on various cannabinoid receptors in the brain. Sacrificing accuracy for simplicity, people in public Most people aren’t aware that the effects are unlike office, the media, and law enforcement use the term marijuana – thus repeated use is rare. And, if given “synthetic marijuana” or the brand names of products the choice, adults would very likely choose to use sold, such as “Spice” or “K2,” that are known to contain marijuana if it were legally available.vii various synthetic cannabinoids.iii The first and most well-known synthetic cannabinoids in laboratory research are known as the JWH Series, but soon after Due to the ongoing prohibition of marijuana, those were banned, newer and less researched emergence of the synthetic cannabinoid market over iv synthetic cannabinoids, such as XLR-11, AB- the last decade has met demand by being a legal or v vi PINACA, and AB-FUBINACA were found in products quasi legal alternative. Because standard drug testing that were still legal. only tests for THC found in plant-based marijuana, synthetic cannabinoid products do not trigger a The substances that were later identified in these positive result. This appealed to active military products were originally discovered by scientific personnel, professional athletes, people on parole, and researchers looking to understand more about the people in treatment for substance misuse who were cannabinoid receptor system in the human brain and among the earliest reported users of these products. immune system. Many of these substances have Another group commonly using synthetic cannabinoids different chemical structures than THC, the main are those suffering from chaotic life situations, often psychoactive ingredient in marijuana, and are full homeless or low income.viii Synthetic cannabinoids agonists at cannabinoid receptors, which can cause became an affordable replacement to marijuana are vii them to produce very different effects than THC, other drugs. which is a partial agonist.This is one possible reason for the higher rates of some of the more extreme side While no specific measures are available, people that effects that are only occasionally seen in adverse continue to use synthetic cannabinoids are perhaps reactions to marijuana. those looking for a cheaper alternative or to pass drug tests, rather than due to preference over marijuana.ix Drug Policy Alliance | 131 West 33rd Street, 15th Floor, New York, NY 10001 Page 1 [email protected] | 212.613.8020 voice | 212.613.8021 fax What’s the difference between synthetic What’s the difference between “Spice”, “K2,” and cannabinoids and marijuana? other synthetic cannabinoid products? Marijuana is a natural plant that grows both in the wild A synthetic cannabinoid product is a branded package and is cultivated for its medicinal properties and for containing herbal matter sprayed or doused with liquid recreational use. Though synthetic cannabinoids are synthetic cannabinoids. “Spice” and “K2” are considered chemical relatives or analogues to examples of very early brands of synthetic cannabinoid substances in marijuana, they are not actually found in products. The first synthetic cannabinoids found in plant-based marijuana and therefore have chemical these products are known as the JWH series, which and pharmacological properties largely unknown were the most extensively studied in laboratory outside of the laboratory.x research. As laws banning the JWH compounds took effect, newer and less researched synthetic Due to the ongoing prohibition of marijuana and cannabinoids such as XR-11, AB-PINACA, and AB- advances in technology that allowed for access to drug FUBINACA were used in products since they had not research and easier chemical production, a market for been banned. synthetic cannabinoids developed in the early 2000s.xi Synthetic cannabinoid products began being produced There are hundreds of different name brands, but and sold in herbal smoking blends as legal marijuana synthetic cannabinoids are not always sold that way. replacements.xii The products are packaged and They may also simply be sold as marijuana might be, branded to suggest a similarity to the effects of as a joint or in a plastic bag without any information as marijuana, but because the material are inert herbal to the actual contents. mixtures doused with synthetic cannabinoids, their appearance, taste, and smell are different. Just because synthetic cannabinoids can be sold in a branded package does not mean the synthetic What are the effects of synthetic cannabinoids? cannabinoids used are always the same.xviii Due to Synthetic cannabinoids are mistakenly considered to lack of regulation there is no incentive for closely mimic the effects of marijuana, but in fact there manufacturers, mostly consisting of clandestine labs in are significant differences. As their name suggests, Asia, to ensure a consistent, high-quality product. synthetic cannabinoids, like THC and other substances These labs are constantly changing formulations in an in marijuana, affect the brain by stimulating activity at effort to work around lawsxix attempting to prohibit various cannabinoid receptors.xiii Although research is them, and brands often contain an inconsistent and limited, preliminary studies suggest that effects include unreliable combination of synthetic cannabinoids.xx feeling stimulated and energetic, increased appetite, Therefore, the difference between synthetic and producing a dream-like state, but can also include cannabinoid products can be as variable as the nausea and vomiting, seizures, aggression and difference from packet to packet of the same brand agitation, as well as respiratory failure and loss of name. Furthermore, material within the packet itself consciousness.xiv Whereas THC, the main may even have varying levels of potency, which could psychoactive substance in marijuana, is a partial result in very high levels of chemicals unintentionally agonist, synthetic cannabinoids are full agonists. ingested.xxi Adverse reactions to synthetic cannabinoids saw calls How risky are synthetic cannabinoid products to poison control centers peak at just under 10,000 in compared to marijuana or other drugs? 2015,xv and the number of emergency room visits in These substances are generally more harmful than the tens of thousandsxvi (these figures have since gone plant-based marijuana. Many of the adverse reactions down). One explanation for the high number of hospital to synthetic cannabinoids have been reported to visits is that other substances in marijuana known to involve dangerous physical symptoms, whereas protect against anxiety and psychotic symptomsxvii adverse reactions to natural marijuana typically involve likely balance out the direct effects of THC on the brain symptoms resembling anxiety and panic, which though but are absent in synthetic cannabinoids. worrisome, are not lethal. In 2012, state public health department officials, poison control centers and CDC Until more research is done on individual synthetic researchers identified 16 cases of acute kidney injury cannabinoids specific causes for these effects will related to use of synthetic cannabinoids in six states remain only partially understood. (Kansas, Oklahoma, Oregon, New York, Rhode Island Drug Policy Alliance | 131 West 33rd Street, 15th Floor, New York, NY 10001 Page 2 [email protected] | 212.613.8020 voice | 212.613.8021 fax and Wyoming).xxii continue to use synthetic cannabinoids are likely those looking for a cheaper alternative or to pass drug tests. The sudden rise of synthetic cannabinoid related calls to poison centers, hospitalizations and even instances Are synthetic cannabinoids legal? of fatal reactions has never been seen with marijuana, For the most part, no. When synthetic cannabinoid which has only ever been indirectly associated with products began to appear in convenience stores in the drug-related deaths, and never shown to result in a mid-2000s they contained substances that were not fatal overdose. Deaths linked to synthetic specifically banned by state or federal drug laws. But cannabinoids do not compare to numbers from drugs by the end of the decade, a few states passed laws to like heroin and cocaine,xxiii and while the brief rise in ban their sale, and in 2011 the DEA used emergency ER visits and poison center calls did signal a protocols to temporarily schedule some of the temporary cause for concern (these figures have since substances found in synthetic cannabinoid products. gone down),xxiv alarmist responses and harsh law The next year, President Obama signed the Synthetic enforcement crackdowns often overshadow the need Drug Abuse Prevention Act, permanently placing for public education and harm reduction measures and several different classes of psychoactive ultimately cause
Load more

Recommended publications
  • Building a 21St Century Approach to Drugs
    Briefing | January 2018 Building a 21st century approach to drugs The ’war on drugs’ is collapsing. Now let’s build the alternative. The ‘war on drugs’ was built on shaky Building a new drug policy foundations. Now, countries around the world from Canada, to Uruguay, Portugal architecture and many US states are beginning to This new approach will ensure that rather than dismantle it piece by piece. Its collapse is penalising or criminalising people involved in the drug good news for people and communities trade, we recognise that it is often injustice, inequality around the world, providing us with the and vulnerability that drives them to engage in that opportunity to build a new approach to trade in the first place, whether that is as consumers, producers or suppliers. Rather than compounding drugs that prioritises, promotes and problems like poverty, powerlessness and stigma with a protects human health and well-being. hard-line prohibitionist approach, which has failed on its This shift, from a criminal justice approach own terms, we must aim to approach drug policy in a to health-based policy making, is essential way that works to address these drivers of engagement if we want to take drug policy into the with the drug trade, and at the same time makes 21st century. It is time for the UK to catch engaging in that trade as harm-free as possible. If we do up, and develop and promote appropriate, this effectively we have the chance to develop and build a whole new paradigm to replace the ‘war on drugs.’ evidence-based, and sustainable alternatives both in the UK and globally.
    [Show full text]
  • Tobaccocontrol40881 293..295
    Endgame visions Tob Control: first published as 10.1136/tc.2010.040881 on 16 February 2012. Downloaded from What are the elements of the tobacco endgame? George Thomson, Richard Edwards, Nick Wilson, Tony Blakely Department of Public Health, ABSTRACT SOME ELEMENTS OF ENDGAME STRATEGIES University of Otago, Wellington, The available literature on tobacco endgames tends to be The following elements attempt to define ‘real’ New Zealand limited to discussing means, targets and difficulties. This endgame strategies, as opposed to purely aspira- Correspondence to article offers additional ideas on the key elements of tional ideas. We visualise endgame strategies as George Thomson, University of endgame strategies and the circumstances in which a process of both planning and implementation. Otago, Box 7343, Wellington these are likely to be adopted and implemented. We The process includes questions such as: how do we South, Wellington 6002, New suggest such strategies will include explicit plans, will reach the endgame goal within the planned time Zealand; [email protected] define the nature of ‘the end of tobacco use/sale’ and period and what other things can be done now or have target dates within 20 years. The likely within the planned period to help achieve the goal? Received 27 February 2011 circumstances for endgame strategy development We suggest that effective government endgame Accepted 2 August 2011 include low (probably under 15% adult smoking) strategies will have the elements of: prevalence and/or rapid prevalence reductions, wide 1. Having an explicit government intention and support and strong political leadership. Even with some plan to achieve close to zero prevalence of or all these circumstances, opposition from business, tobacco use.
    [Show full text]
  • NIDA's Drug Facts on Synthetic Cannabinoids (K2/Spice)
    Synthetic Cannabinoids (K2/Spice) Revised February 2018 What are synthetic cannabinoids? Synthetic cannabinoids are human-made mind-altering chemicals that are either sprayed on dried, shredded plant material so they can be smoked or sold as liquids to be vaporized and inhaled in e-cigarettes and other devices. These products are also known as herbal or liquid incense. These chemicals are called cannabinoids because they are similar to chemicals found in the marijuana plant. Because of this similarity, synthetic cannabinoids are sometimes misleadingly called "synthetic marijuana" (or "fake weed"), and they are often marketed as safe, legal alternatives to that drug. In fact, they are not safe and may affect the brain much more powerfully than marijuana; their actual effects can be unpredictable and, in some cases, more dangerous or even life-threatening. Synthetic cannabinoids are part of a group of drugs called new psychoactive substances (NPS). NPS are unregulated mind-altering substances that have become newly available on the market and are intended to produce the same effects as illegal drugs. Some of these substances may have been around for years but have reentered the market in altered chemical forms, or due to renewed popularity. False Advertising Synthetic cannabinoid products are often labeled "not for human consumption." Labels also often claim that they contain "natural" material taken from a variety of plants. However, the only parts of these products that are natural are the dried plant materials. Chemical tests show that the active, mind-altering ingredients are cannabinoid compounds made in laboratories. Synthetic Cannabinoids • February 2018 • Page 1 Manufacturers sell these products in colorful foil packages and plastic bottles to attract consumers.
    [Show full text]
  • Frequently Asked Questions About Synthetic Drugs
    FREQUENTLY ASKED QUESTIONS ABOUT SYNTHETIC DRUGS WHAT ARE SYNTHETIC DRUGS? WHAT DOES THE PACKAGING OF SYNTHETIC CANNABINOIDS LOOK LIKE? A SYNTHETIC DRUG, ALSO REFERRED TO AS A Many of the products are sold in colorful packets with names DESIGNER DRUG, IS A CHEMICAL INTENDED TO that appeal to adolescents and young adults. Manufacturers IMITATE THE PROPERTIES AND EFFECTS OF A label the packages as “not for human consumption” and KNOWN HALLUCINOGEN OR NARCOTIC AND market the products as incense or potpourri to mask the MAY HAVE UNKNOWN SIDE EFFECTS OR CAUSE intended purpose and to avoid regulatory oversight of AN ADVERSE REACTION. THESE DRUGS ARE the manufacturing process. You can view examples of the packaging on page 3. CREATED IN ORDER TO EVADE RESTRICTIONS AGAINST ILLEGAL SUBSTANCES. ARE SYNTHETIC CANNABINOIDS ARE SYNTHETIC DRUGS LEGAL IN TEXAS? DANGEROUS? No. Under state law, it is a crime to manufacture, deliver or Synthetic cannabinoids possess a synthetic drug. are illegal, dangerous, highly addictive and WHAT ARE SYNTHETIC CANNABINOIDS? potentially deadly. One Synthetic cannabinoids are commonly referred to as K2, of the original chemists Kush, Spice, synthetic marijuana and fake weed. They are who designed synthetic a mix of plant matter sprayed with chemicals in sometimes cannabis for research purposes, John Huffman, Ph.D., likened dangerously high proportions, falsely marketed as “legal recreational use of synthetic drugs to playing Russian highs” and smoked like marijuana. roulette. The contents and effects of synthetic cannabinoids WHERE ARE SYNTHETIC CANNABINOIDS SOLD? are unpredictable due to a constantly changing variety of Synthetic cannabinoids are relatively inexpensive and sold chemicals used in manufacturing processes devoid of quality in convenience stores, smoke shops, novelty stores, on the controls and government regulatory oversight.
    [Show full text]
  • Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back
    International Journal of Molecular Sciences Review Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back Osnat Almogi-Hazan * and Reuven Or Laboratory of Immunotherapy and Bone Marrow Transplantation, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; [email protected] * Correspondence: [email protected] Received: 21 May 2020; Accepted: 19 June 2020; Published: 23 June 2020 Abstract: The Cannabis plant contains numerous components, including cannabinoids and other active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid system. Cannabinoids affect the nervous system and play significant roles in the regulation of the immune system. While Cannabis is not yet registered as a drug, the potential of cannabinoid-based medicines for the treatment of various conditions has led many countries to authorize their clinical use. However, the data from basic and medical research dedicated to medical Cannabis is currently limited. A variety of pathological conditions involve dysregulation of the immune system. For example, in cancer, immune surveillance and cancer immuno-editing result in immune tolerance. On the other hand, in autoimmune diseases increased immune activity causes tissue damage. Immuno-modulating therapies can regulate the immune system and therefore the immune-regulatory properties of cannabinoids, suggest their use in the therapy of immune related disorders. In this contemporary review, we discuss the roles of the endocannabinoid system in immunity and explore the emerging data about the effects of cannabinoids on the immune response in different pathologies. In addition, we discuss the complexities of using cannabinoid-based treatments in each of these conditions.
    [Show full text]
  • Synthetic Cannabis
    Global emergence of synthetic cannabinoids Source: https://www.unodc.org/LSS/SubstanceGroup/Details/ae45ce06-6d33-4f5f-916a- e873f07bde02 Source: UNODC questionnaire on NPS, 2012 Background The appearance of ‘herbal highs’ in the market is not a new phenomenon. Such products usually consisted of plant mixtures with little psychoactive effects. Since 2004, however, the composition of these herbal products seems to have substantially changed to include potent new psychoactive compounds known as synthetic cannabinoids. Research on the mechanism of cannabis activity dates back several decades when molecules with similar behaviour to Δ9-tetrahydrocannabinol (THC) were first examined. A synthetic analogue of THC , ‘HU-210’, was first synthesized in Israel in 1988[1]and is considered to have a potency of at least 100 times more than THC. Due to its similar chemical structure to THC, ‘HU-210’ is regarded as a ‘classical cannabinoid’ and has been found in synthetic cannabinoids sold in the United States and other countries. Non-classical cannabinoids include cyclohexylphenols or 3-arylcyclohexanols (‘CP’compounds). ‘CP’ compounds were developed as potential analgesics by a pharmaceutical company in the 1980s. Respondents to the UNODC questionnaire on NPS have reported the emergence of CP-47,497 and CP-47,497-C8 in numerous countries in all regions except Africa since 2009. Other structurally dissimilar varieties of synthetic cannabinoids unrelated to THC have also emerged on the market. These include aminoalkylindoles, such as naphthoylindoles (e.g. JWH-018), phenylacetylindoles (e.g. JWH-250), and benzoylindoles (e.g. AM-2233).[2] JWH-018, arguably the most widely known synthetic cannabinoid, belongs to the group of aminoalkylindoles and is considered to be three times as potent as THC.
    [Show full text]
  • The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of Lncap Prostate Cancer Cells
    OPEN Prostate Cancer and Prostatic Diseases (2016) 19, 248–257 www.nature.com/pcan ORIGINAL ARTICLE The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells C Morell1, A Bort1, D Vara2, A Ramos-Torres1, N Rodríguez-Henche1 and I Díaz-Laviada1 BACKGROUND: Neuroendocrine (NE) differentiation represents a common feature of prostate cancer and is associated with accelerated disease progression and poor clinical outcome. Nowadays, there is no treatment for this aggressive form of prostate cancer. The aim of this study was to determine the influence of the cannabinoid WIN 55,212-2 (WIN, a non-selective cannabinoid CB1 and CB2 receptor agonist) on the NE differentiation of prostate cancer cells. METHODS: NE differentiation of prostate cancer LNCaP cells was induced by serum deprivation or by incubation with interleukin-6, for 6 days. Levels of NE markers and signaling proteins were determined by western blotting. Levels of cannabinoid receptors were determined by quantitative PCR. The involvement of signaling cascades was investigated by pharmacological inhibition and small interfering RNA. RESULTS: The differentiated LNCaP cells exhibited neurite outgrowth, and increased the expression of the typical NE markers neuron-specific enolase and βIII tubulin (βIII Tub). Treatment with 3 μM WIN inhibited NK differentiation of LNCaP cells. The cannabinoid WIN downregulated the PI3K/Akt/mTOR signaling pathway, resulting in NE differentiation inhibition. In addition, an activation of AMP-activated protein kinase (AMPK) was observed in WIN-treated cells, which correlated with a decrease in the NE markers expression. Our results also show that during NE differentiation the expression of cannabinoid receptors CB1 and CB2 dramatically decreases.
    [Show full text]
  • Criminal Injustice: Cannabis & the Rise of the Carceral State
    CANNABIS & THE RISE OF THE CARCERAL STATE PART I: POLICING 1 PART I THE POLICING OF MARIJUANA PROHIBITION CRIMINAL INJUSTICE: CANNABIS & THE RISE OF THE CARCERAL STATE BROUGHT TO YOU BY: THE LAST PRISONER PROJECT COPYRIGHT © 2020 NATALIE PAPILLION ALL RIGHTS RESERVED The Last Prisoner Project (LPP) is a But our work cannot end there. nonprofit organization dedicated to cannabis criminal justice Now, more than ever, it is reform. imperative that we seize on the opportunity to reform our justice As the United States moves away system through cannabis-related from the criminalization of policy solutions that work to end cannabis, giving rise to a major the vicious cycle of Americans new industry, there remains the being caught up in every aspect of fundamental injustice inflicted the criminal legal system. upon those who have suffered under America’s unjust policy of I am hopeful that this work will cannabis prohibition. enable us to more effectively push for broad, systemic change Through intervention, advocacy so that we may see the day where and awareness campaigns, the the last cannabis prisoner walks Last Prisoner Project works to free. redress the past and continuing harms of these unjust laws and policies. To date, a key focus of LPP has been our direct service work to S A R A H G E R S T E N release currently incarcerated E X E C U T I V E D I R E C T O R , cannabis prisoners. L A S T P R I S O N E R P R O J E C T On July 28, 1973, President Richard Nixon signed Reorganization Plan No.
    [Show full text]
  • The Use of Cannabinoids in Animals and Therapeutic Implications for Veterinary Medicine: a Review
    Veterinarni Medicina, 61, 2016 (3): 111–122 Review Article doi: 10.17221/8762-VETMED The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review L. Landa1, A. Sulcova2, P. Gbelec3 1Faculty of Medicine, Masaryk University, Brno, Czech Republic 2Central European Institute of Technology, Masaryk University, Brno, Czech Republic 3Veterinary Hospital and Ambulance AA Vet, Prague, Czech Republic ABSTRACT: Cannabinoids/medical marijuana and their possible therapeutic use have received increased atten- tion in human medicine during the last years. This increased attention is also an issue for veterinarians because particularly companion animal owners now show an increased interest in the use of these compounds in veteri- nary medicine. This review sets out to comprehensively summarise well known facts concerning properties of cannabinoids, their mechanisms of action, role of cannabinoid receptors and their classification. It outlines the main pharmacological effects of cannabinoids in laboratory rodents and it also discusses examples of possible beneficial use in other animal species (ferrets, cats, dogs, monkeys) that have been reported in the scientific lit- erature. Finally, the article deals with the prospective use of cannabinoids in veterinary medicine. We have not intended to review the topic of cannabinoids in an exhaustive manner; rather, our aim was to provide both the scientific community and clinical veterinarians with a brief, concise and understandable overview of the use of cannabinoids in veterinary
    [Show full text]
  • Pharmacodynamics of Cannabinoids
    Open Access Archives of Pharmacy and Pharmaceutical Sciences Review Article Pharmacodynamics of cannabinoids Alexandra Sulcova* ISSN ICCI - International Cannabis and Cannabinoids Institute, Jachymova 26/2, 110 00 Praha, 2639-992X Czech Republic “Pharmacodynamics of cannabinoids “(i.e. a set of biological effects elicited in the *Address for Correspondence: Alexandra Sulcova, M.D, Ph.D, Professor of Pharmacology, living organism by interaction with its biochemical and biophysical functions up to the FCMA, FECNP, FCINP, ICCI - International cellular level) is studied for a long time during both, physiological and pathological Cannabis and Cannabinoids Institute, Jachymova conditions. Cannabinoids received their names according to their natural occurrence 26/2, 110 00 Praha, Czech Republic, Tel: 420 732167678; Email: [email protected] as constituents of Cannabis sativa L. (marijuana). The species was classiied in the “Linnaeus’s Species Plantarum (1753)”, the word “sativa” means things that are Submitted: 12 April 2019 Approved: 07 May 2019 cultivated [1]. For ages, people have used cannabis-based preparations for healing and Published: 08 May 2019 pain suppression until the discovery (in 1897) of aspirin (acetylsalicylic acid) which contemporary medicine uses until today. Chemical investigation of marijuana conirmed Copyright: © 2019 Sulcova A. This is an open access article distributed under the Creative various cannabinoid-type components called cannabinoids (presently estimated at Commons Attribution License, which permits about 150). Regarding their possible pharmacodynamic effects, tetrahydrocannabinol unrestricted use, distribution, and reproduction (THC) and cannabidiol (CBD) are the most explored. The determination of THC structure in any medium, provided the original work is properly cited by means of nuclear magnetic resonance imaging increased sharply the number of professional scientiic reports dealing with the studies of THC pharmacodynamic mechanisms of action [2].
    [Show full text]
  • Federal Cannabis Regulations Working Group
    FEDERAL CANNABIS REGULATIONS WORKING GROUP: CORE GROUP MEMBERS a working group of experts convened by the Drug Policy Alliance to explore and develop policy recommendations for federal cannabis regulations grounded in public health, equity, and justice reform considerations. QUEEN ADESUYI Queen Adesuyi is a policy manager at the Drug Policy Alliance’s National Affairs office in Washington, D.C., where she works to advance several of DPA’s legislative priorities on the federal level, including marijuana legalization with a racial justice focus, drug decriminalization, and eliminating punitive consequences for drug use and previous convictions. She also advocates for equity/racial justice in plans for the District of Columbia’s emerging marijuana industry, in addition to advancing overdose prevention measures and harm reduction in the District. While at DPA, Queen saw through the introduction of the Marijuana Justice Act, Congress’ first marijuana reform bill that addressed racial justice and justice reform issues. She helped convene and co-leads the Marijuana Justice Coalition. Under her co-leadership, the Marijuana Justice Coalition has worked on the introduction and the historic passage of the Marijuana Opportunity Reinvestment & Expungement (MORE) Act by the U.S. House of Representatives in the 116th Congress. The Coalition continues to work to see the continued improvement of the MORE Act and its successful reintroduction and movement through both chambers of Congress. AAMRA AHMAD Aamra Ahmad is currently the Senior Policy Counsel for the Justice Division of the ACLU and an advocate for federal criminal justice reform. She previously served as legislative counsel to Congressman Bobby Scott (VA-3) and in her previous role at the Federal Public & Community Defenders, oversaw their national litigation strategy that contributed to reduced sentences for over 3,363 people incarcerated under racially unjust drug laws.
    [Show full text]
  • Synthetic Cannabinoids (K2/Spice)
    Synthetic Cannabinoids (K2/Spice) Revised June 2020 What are synthetic cannabinoids? Synthetic cannabinoids are human-made mind-altering chemicals that are either sprayed on dried, shredded plant material so they can be smoked or sold as liquids to be vaporized and inhaled in e-cigarettes and other devices. These products are also known as herbal or liquid incense. These chemicals are called cannabinoids because they are similar to chemicals found in the marijuana plant. Because of this similarity, synthetic cannabinoids are sometimes misleadingly called synthetic marijuana (or fake weed), and they are often marketed as safe, legal alternatives to that drug. In fact, they are not safe and may affect the brain much more powerfully than marijuana; their actual effects can be unpredictable and, in some cases, more dangerous or even life-threatening. Synthetic cannabinoids are part of a group of drugs called new psychoactive substances (NPS). NPS are unregulated mind-altering substances that have become newly available on the market and are intended to produce the same effects as illegal drugs. Some of these substances may have been around for years but have reentered the market in altered chemical forms, or due to renewed popularity. False Advertising Synthetic cannabinoid products are often labeled "not for human consumption." Labels also often claim that they contain natural material taken from a variety of plants. However, the only parts of these products that are natural are the dried plant materials. Chemical tests show that the active, mind-altering ingredients are cannabinoid compounds made in laboratories. Synthetic Cannabinoids • June 2020 • Page 1 Manufacturers sell these products in colorful foil packages and plastic bottles to attract consumers.
    [Show full text]